- Home
- KGEI vs XOMA Comparison
KGEI vs XOMA Comparison
Compare KGEI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- XOMA
- Stock Information
- Founded
- KGEI 2008
- XOMA 1981
- Country
- KGEI United States
- XOMA United States
- Employees
- KGEI N/A
- XOMA N/A
- Industry
- KGEI
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- KGEI
- XOMA Health Care
- Exchange
- KGEI Nasdaq
- XOMA Nasdaq
- Market Cap
- KGEI 262.6M
- XOMA 250.1M
- IPO Year
- KGEI N/A
- XOMA N/A
- Fundamental
- Price
- KGEI $8.91
- XOMA $19.30
- Analyst Decision
- KGEI Strong Buy
- XOMA Strong Buy
- Analyst Count
- KGEI 1
- XOMA 2
- Target Price
- KGEI $11.00
- XOMA $72.00
- AVG Volume (30 Days)
- KGEI 126.3K
- XOMA 30.1K
- Earning Date
- KGEI 03-25-2025
- XOMA 03-17-2025
- Dividend Yield
- KGEI N/A
- XOMA N/A
- EPS Growth
- KGEI N/A
- XOMA N/A
- EPS
- KGEI 0.50
- XOMA N/A
- Revenue
- KGEI $58,651,000.00
- XOMA $28,487,000.00
- Revenue This Year
- KGEI $39.41
- XOMA $29.60
- Revenue Next Year
- KGEI $24.46
- XOMA $34.18
- P/E Ratio
- KGEI $17.70
- XOMA N/A
- Revenue Growth
- KGEI 15.91
- XOMA 498.72
- 52 Week Low
- KGEI $2.85
- XOMA $19.12
- 52 Week High
- KGEI $9.89
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- KGEI 56.36
- XOMA 27.79
- Support Level
- KGEI $6.57
- XOMA $20.45
- Resistance Level
- KGEI $8.71
- XOMA $21.45
- Average True Range (ATR)
- KGEI 0.57
- XOMA 0.80
- MACD
- KGEI 0.08
- XOMA 0.05
- Stochastic Oscillator
- KGEI 78.97
- XOMA 6.49
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.